Clinical Presentation, Outcomes, and Treatment of Membranous Nephropathy after Transplantation

Table 4

Risk factors for posttransplant MN remission.

Variables	Partial or complete remission; N=31	No remission; N=10	p value
Recipient age (years old), mean ± DP	46.8 ± 12.3	57.3 ± 13.2	0.027
Time after KT at diagnosis (months), mean ± DP	54.6 ± 53.7	49.4 ± 46.4	0.782
Serum creatinine at diagnosis (mg/dL), mean ± DP	1.6 ± 0.7	2.1 ± 2.3	0.351
Proteinuria at diagnosis (g/24h or g/g), mean ± DP	2.9 ± 3.2	4.1 ± 3.5	0.337
Living donor, n(%)	23 (74.2)	3 (30)	0.022
RAAS blockade, n(%)	26 (83)	9 (90)	1.000
Change in maintenance IS after diagnosis, n(%)	16 (51)	4 (40)	0.719
Treatment with high dose steroids, n(%)	14 (45.2)	3 (30)	0.480
Treatment with Ponticelli scheme, n(%)	1 (3.2)	2 (20)	0.142

KT: kidney transplant; RAAS: renin angiotensin aldosterone system.